通路

基因数

P值

FDR

Pathways in cancer

48

1.3E−26

1.4E−24

Proteoglycans in cancer

27

2.6E−18

1.5E−16

Endocrine resistance

20

4.4E−17

1.6E−15

PI3K-Akt signaling pathway

29

3.1E−14

8.7E−13

Focal adhesion

22

3.7E−13

6.9E−12

Human cytomegalovirus infection

23

3.7E−13

6.9E−12

Prostate cancer

16

3.7E−12

5.9E−11

Progesterone-mediated oocyte maturation

16

7.9E−12

1.1E−10

Ras signaling pathway

22

8.5E−12

1.1E−10

Chemical carcinogenesis-receptor activation

21

9.6E−12

1.1E−10

Melanoma

14

1.4E−11

1.5E−10

Human papillomavirus infection

25

1.9E−11

1.7E−10

Glioma

14

2.5E−11

2.1E−10

EGFR tyrosine kinase inhibitor resistance

14

4.9E−11

3.9E−10

Estrogen signaling pathway

17

6.2E−11

4.6E−10

Bladder cancer

11

1.5E−10

1.1E−09

Non-small cell lung cancer

13

2.4E−10

1.5E−09

Relaxin signaling pathway

16

2.5E−10

1.5E−09

Pancreatic cancer

13

4.7E−10

2.8E−09

Rap1 signaling pathway

19

5.7E−10

3.2E−09